Moleculin Biotech Statistics Share Statistics Moleculin Biotech has 30.21M
shares outstanding. The number of shares has increased by 747.22%
in one year.
Shares Outstanding 30.21M Shares Change (YoY) 747.22% Shares Change (QoQ) 72.13% Owned by Institutions (%) 15.82% Shares Floating 27.57M Failed to Deliver (FTD) Shares 470,080 FTD / Avg. Volume 8.67%
Short Selling Information The latest short interest is 5.23M, so 17.31% of the outstanding
shares have been sold short.
Short Interest 5.23M Short % of Shares Out 17.31% Short % of Float 17.38% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.27 and the forward
PE ratio is -0.5.
Moleculin Biotech's PEG ratio is
0.
PE Ratio -0.27 Forward PE -0.5 PS Ratio 0 Forward PS 0.3 PB Ratio 0.98 P/FCF Ratio -0.25 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Moleculin Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.97,
with a Debt / Equity ratio of 0.08.
Current Ratio 0.97 Quick Ratio 0.97 Debt / Equity 0.08 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.28M Employee Count 17 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -72.44% in the
last 52 weeks. The beta is 1.4, so Moleculin Biotech's
price volatility has been higher than the market average.
Beta 1.4 52-Week Price Change -72.44% 50-Day Moving Average 0.6 200-Day Moving Average 1.35 Relative Strength Index (RSI) 52.76 Average Volume (20 Days) 5,422,572
Income Statement
Revenue n/a Gross Profit n/a Operating Income -26.64M Net Income -21.76M EBITDA -21.64M EBIT -21.76M Earnings Per Share (EPS) -6.32
Full Income Statement Balance Sheet The company has 4.28M in cash and 478K in
debt, giving a net cash position of 3.8M.
Cash & Cash Equivalents 4.28M Total Debt 478K Net Cash 3.8M Retained Earnings -153.37M Total Assets 21.01M Working Capital 2.44M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -23.86M
and capital expenditures -13K, giving a free cash flow of -23.88M.
Operating Cash Flow -23.86M Capital Expenditures -13K Free Cash Flow -23.88M FCF Per Share -6.93
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields MBRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for MBRX is $4,
which is 545.2% higher than the current price. The consensus rating is "Buy".
Price Target $4 Price Target Difference 545.2% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 22, 2024. It was a
backward
split with a ratio of 1:15.
Last Split Date Mar 22, 2024 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -13.99 Piotroski F-Score 2
